Abstract
BACKGROUND:Recent research suggests that administration of serotonin or 5-hydroxytryptamine (5-HT) its precursors or agonists of ttheir receptors can modulate glycemia in rodents; being 5 HT2A the main receptors involved in glycemia reduction. Therefore, we decided to investigate the effect of TR3370 a quipazine analogue, over glycemia.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings for Annual Meeting of The Japanese Pharmacological Society
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
